A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System (DSS) (DSS)

A Postmarket Surveillance Study of the Paradigm Spine Dynamic Stabilization System(DSS)

The purpose of the Post-Market Surveillance study is to evaluate safety.

Study Overview

• Status: Terminated
• Conditions: Spondylolisthesis; Kyphosis; Neurologic Deficits; Pseudarthrosis
• Intervention / Treatment: Device: Dynamic Stabilization System (DSS)

Detailed Description

Paradigm Spine Dynamic Stabilization System (DSS) study is a prospective, multi-center, literature controlled study.

• Study Type: Interventional
• Enrollment (Actual): 1
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • California
    • Sacramento, California, United States, 95816
      • University of California, Davis Medical Center

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 21 years to 85 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Patient is skeletally mature (21-85 years old).
• Patient has degenerative spondylolisthesis (Grade 1-3) with objective evidence of neurologic impairment, kyphosis, and/or failed previous fusion (pseudarthrosis) at index level.
• Capable and willing to comply with the requirements unique to the study, adhere to the post-operative treatment and management program, and return for required follow-up examinations.
• Surgeon has determined that DSS™ System is an appropriate treatment for the patient without regard to the study.

Exclusion Criteria:

• The need for interbody cages, allograft, or any other assistance during surgery. Device is only to be used with autograft per FDA approved indications.
• Any medical, mental or surgical condition precluding the potential benefit of spinal surgery or surgery in general.
• Acute or chronic systemic, spinal or localized infections.
• Active, severe systemic and metabolic diseases.
• Obesity defined as Body Mass Index > 35.
• Subject is pregnant or interested in becoming pregnant in the next 36 months.
• Dependency on pharmaceutical drugs, drug abuse, or alcoholism.
• Lack of patient cooperation.
• Foreign body sensitivity to the implant material.
• Degenerative scoliosis greater than 25 degrees.
• Grade 4 degenerative spondylolisthesis (>75% slip).
• Significant osteopenia A screening questionnaire for osteopenia, SCORE (Simple Calculated Osteoporosis Risk Estimation), will be used to screen patients who require a DEXA bone mineral density measurement. If DEXA is required*, exclusion will be defined as a DEXA bone density measured T score of ≤ -1.0 (The World Health Organization definition of osteopenia).
• Soft tissue deficit not allowing wound closure.
• Congenital abnormalities, tumors or other conditions that would prevent secure component fixation that has the potential to decrease the useful life of the device.
• Inadequate pedicles or vertebral body geometry of the thoracic, lumbar and sacral vertebrae.
• Bony lumbar spinal stenosis not related to the primary degenerative spondylolisthesis indication.
• Pars defect.
• Clinically compromised vertebral bodies at affected level due to current or past trauma.
• Prisoner or ward of the state.
• Currently in litigation regarding a spinal condition.
• Known allergy to titanium, titanium alloys, CoCrMo, polyethylene or MR contrast agents.
• Is currently involved in a study of another investigational product for similar purpose.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Dynamic Stabilization System; Dynamic Stabilization System (DSS) System	Device: Dynamic Stabilization System (DSS); Dynamic Stabilization System

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of Participants Who Have an Incidence of Serious or Device Related Adverse Events Due to Device or Procedure.	The safety endpoint is defined as the incidence of serious or device related adverse events attributable to the device or procedure. Reoperations, revisions or removals of the Dynamic Stabilization System (DSS) System implant will be evaluated.	6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Measurement of Lower Back Pain as Assessed by Visual Analog Scale	Lower back pain as measured by the Visual Analog Scale (VAS) on the scale from 0 (no pain) to 100 (worst imaginable pain)	6 months
Measurement of Right Leg Pain as Assessed by Visual Analog Scale	Right leg pain as measured by the Visual Analog Scale (VAS) on the scale from 0 (no pain) to 100 (worst imaginable pain)	6 months
Measurement of Left Leg Pain as Assessed by Visual Analog Scale	Left leg pain as measured by the Visual Analog Scale (VAS) on the scale from 0 (no pain) to 100 (worst imaginable pain)	6 months
Number of Participants With Improved Health as Measured by the EuroQOL Health Related Qualify of Life- 5 Dimensions-3 Level (EQ-5D-3L) Health Questionnaire Compared to Baseline.	The EQ-5D-3L is a standardized instrument used as a measure of health outcomes. It contains questions in 5 dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and provides a simple descriptive profile and single index for health status preference. In addition, there is a Visual Analog Scale (VAS). The VAS is the participant's rating of their health on a scale of 0 "worst imaginable health state" to 100 "best imaginable health state".	Pre-Op, 6 weeks, 6 months, 12 months, and 24 months
Assessment of Back Pain Using the Oswestry Low Back Pain Disability Index (ODI).	ODI is a questionnaire that provides information on back and the affects on managing every day life by diving questions into 10 sections. The total possible score for each section is 0-5. The scores are then converted into percentages ranging from 0% (minimal disability) to 100% (maximum possible disability).	6 months

Collaborators and Investigators

• Sponsor: Paradigm Spine
• Collaborators: MCRA
• Investigators: Study Director: Gitela Gandelman, Paradigm Spine LLC

Study record dates

Study Major Dates

• Study Start: September 1, 2011
• Primary Completion (Actual): September 1, 2016
• Study Completion (Actual): September 1, 2016

Study Registration Dates

• First Submitted: October 18, 2011
• First Submitted That Met QC Criteria: October 26, 2011
• First Posted (Estimate): October 27, 2011

Study Record Updates

• Last Update Posted (Actual): February 19, 2020
• Last Update Submitted That Met QC Criteria: February 6, 2020
• Last Verified: February 1, 2020

More Information

Terms related to this study

• Keywords: Spondylolisthesis; Kyphosis; Neurologic impairment; Pseudarthrosis
• Additional Relevant MeSH Terms: Nervous System Diseases; Fractures, Bone; Wounds and Injuries; Musculoskeletal Diseases; Spinal Diseases; Bone Diseases; Spinal Curvatures; Spondylolysis; Spondylosis; Fractures, Ununited; Spondylolisthesis; Neurologic Manifestations; Kyphosis; Pseudarthrosis
• Other Study ID Numbers: Dynamic Stabilization System